Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anhedonia in schizophrenia]

G Loas1, P Boyer, A Legrand

  • 1Secteur Hospitalo-Universitaire de Psychiatrie, Hôpital Pinel, Amiens.

L'Encephale
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in the pharmacokinetics of anticancer drugs: a systematic review.

ESMO open·2024
Same author

TORPP - Turtles, One Health Research & Plastic Pollution: A multidisciplinary consortium to evaluate the environmental and health impact of Micro/NanoPlastics (MNPs) pollution.

One health (Amsterdam, Netherlands)·2024
Same author

Prognostic value of total, free and lipoprotein fraction-bound plasma mitotane levels in advanced adrenocortical carcinoma: a prospective study of the ENDOCAN-COMETE-Cancer network.

Journal of endocrinological investigation·2024
Same author

Use of spironolactone for the treatment of acne in adolescent girls.

Annales de dermatologie et de venereologie·2024
Same author

Stand up to better pay attention, sit down to better subtract: a new perspective on the advantage of cognitive-motor interactions.

Psychological research·2023
Same author

Is better selective attention while standing possible without cost on postural sway?

Quarterly journal of experimental psychology (2006)·2022
Same journal

Measuring antidepressant side effects in military personnel - Clinical validation of the French version of the UKU-SERS-Pat Scale: A comparative study of patient and clinician ratings.

L'Encephale·2026
Same journal

[Empowerment in addictology].

L'Encephale·2026
Same journal

Evaluation of the links between smoking and conspiracy mentality.

L'Encephale·2026
Same journal

Use of a relevance assessment tool in therapeutic residential care: A real world study.

L'Encephale·2026
Same journal

Prevalence and characteristics of domestic violence in a sample of adult psychiatric outpatients: A cross-sectional study.

L'Encephale·2026
Same journal

From representations to practice: how professionals describe supporting parents with psychiatric or somatic illness or disability.

L'Encephale·2026
See all related articles

Anhedonia, the inability to feel pleasure, is a potential marker for schizophrenia. This study found schizophrenic individuals exhibit significantly higher anhedonia than healthy controls.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Context:

  • Schizophrenia is a complex mental disorder.
  • Anhedonia is a core symptom in schizophrenia, impacting quality of life.
  • Understanding anhedonia's role is crucial for diagnosis and treatment.

Purpose:

  • To investigate anhedonia in individuals diagnosed with schizophrenia.
  • To assess the reliability and validity of anhedonia rating scales in this population.
  • To explore the relationship between anhedonia, depression, and patient status (inpatient/outpatient).

Summary:

  • A study compared anhedonia levels in 61 schizophrenia patients and 56 healthy controls using the Physical Anhedonia Scale (PAS) and Fawcett's Pleasure Scale (FCPCS-PP).
  • Schizophrenia patients showed significantly higher anhedonia (higher PAS scores, lower FCPCS-PP scores) compared to controls.

Related Experiment Videos

  • No significant differences in anhedonia were found between depressed and non-depressed schizophrenic subgroups or between inpatient and outpatient groups.

    • Impact:

    • Anhedonia may serve as a potential diagnostic marker for schizophrenia.
    • The findings suggest anhedonia is a continuous trait within schizophrenia, not indicative of a distinct subgroup.
    • This research contributes to a better understanding of schizophrenia's symptomatic profile and potential biomarkers.